A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease
Authors
Keywords
-
Journal
Frontiers in Cardiovascular Medicine
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-16
DOI
10.3389/fcvm.2021.653655
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
- (2021) Yu Zuo et al. Scientific Reports
- Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome
- (2020) Hekmat B. Khoukaz et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Hypofibrinolytic state and high thrombin generation may play a major role in SARS‐COV2 associated thrombosis
- (2020) Christophe Nougier et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Structural Insights into the Mechanism of a Nanobody That Stabilizes PAI-1 and Modulates Its Activity
- (2020) Machteld Sillen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome
- (2020) Sujin Kang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Covid-19: Critically ill patients treated with arthritis drug tocilizumab show improved outcomes, researchers report
- (2020) Jacqui Wise BMJ-British Medical Journal
- Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition
- (2020) Machteld Sillen et al. Frontiers in Cardiovascular Medicine
- The obesity transition: stages of the global epidemic
- (2019) Lindsay M Jaacks et al. Lancet Diabetes & Endocrinology
- Adipokine Dysregulation and Insulin Resistance with Atherosclerotic Vascular Disease: Metabolic Syndrome or Independent Sequelae?
- (2019) Mohan Satish et al. Journal of Cardiovascular Translational Research
- ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K/AKT pathway in glioma
- (2019) Xiaonan Xi et al. Cell Death & Disease
- Molecular mechanism of two nanobodies that inhibit PAI‐1 activity reveals a modulation at distinct stages of the PAI‐1/plasminogen activator interaction
- (2019) Machteld Sillen et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The Global Epidemic of the Metabolic Syndrome
- (2018) Mohammad G. Saklayen CURRENT HYPERTENSION REPORTS
- The roles of PAI-1 gene polymorphisms in atherosclerotic diseases: A systematic review and meta-analysis involving 149,908 subjects
- (2018) Yu Liu et al. GENE
- Plasminogen activator inhibitor-1: a risk factor for deep vein thrombosis after total hip arthroplasty
- (2018) Ju Tang et al. Journal of Orthopaedic Surgery and Research
- Plasminogen Activator Inhibitor 1 for Predicting Sepsis Severity and Mortality Outcomes: A Systematic Review and Meta-Analysis
- (2018) Timothy L. Tipoe et al. Frontiers in Immunology
- PAI-1 Exacerbates White Adipose Tissue Dysfunction and Metabolic Dysregulation in High Fat Diet-Induced Obesity
- (2018) Lin Wang et al. Frontiers in Pharmacology
- Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study
- (2017) Aniket Prabhudesai et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Relationship between plasma plasminogen activator inhibitor-1 and hypertension in American Indians
- (2017) Hao Peng et al. JOURNAL OF HYPERTENSION
- The Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis
- (2016) Panagiotis Flevaris et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Plasminogen activator inhibitor and the risk of cardiovascular disease: The Framingham Heart Study
- (2016) G.H. Tofler et al. THROMBOSIS RESEARCH
- Thrombosis in the setting of obesity or inflammatory bowel disease
- (2016) S. R. Lentz Hematology-American Society of Hematology Education Program
- Plasminogen Activator Inhibitor-1 in Cancer: Rationale and Insight for Future Therapeutic Testing
- (2015) V. R. Placencio et al. CANCER RESEARCH
- The association of clot lysis time with total obesity is partly independent from the association of PAI-1 with central obesity in African adults
- (2015) Philna Eksteen et al. THROMBOSIS RESEARCH
- Altered Daytime Fluctuation Pattern of Plasminogen Activator Inhibitor 1 in Type 2 Diabetes Patients with Coronary Artery Disease: A Strong Association with Persistently Elevated Plasma Insulin, Increased Insulin Resistance, and Abdominal Obesity
- (2015) Katarina Lalić et al. International Journal of Endocrinology
- Targeted Inhibition of PAI-1 Activity Impairs Epithelial Migration and Wound Closure Following Cutaneous Injury
- (2015) Tessa M. Simone et al. Advances in Wound Care
- Innovative thrombolytic strategy using a heterodimer diabody against TAFI and PAI-1 in mouse models of thrombosis and stroke
- (2014) T. Wyseure et al. BLOOD
- Epidemiologic and Molecular Prognostic Review of Glioblastoma
- (2014) J. P. Thakkar et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Increased thrombotic and impaired fibrinolytic response to acute exercise in patients with essential hypertension: The effect of treatment with an angiotensin II receptor blocker
- (2014) E Gavriilaki et al. JOURNAL OF HUMAN HYPERTENSION
- Mechanism linking diabetes mellitus and obesity
- (2014) Abdullah Algoblan et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Mechanisms of thrombosis in obesity
- (2013) Ilya O. Blokhin et al. CURRENT OPINION IN HEMATOLOGY
- 2013 ESH/ESC Guidelines for the management of arterial hypertension
- (2013) EUROPEAN HEART JOURNAL
- Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
- (2013) L. E. Gralinski et al. mBio
- Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study
- (2012) Jenny Hernestål-Boman et al. Cardiovascular Diabetology
- Gender-Specific Association of the Plasminogen Activator Inhibitor-1 4G/5G Polymorphism With Central Arterial Blood Pressure
- (2011) H. M. Bjorck et al. AMERICAN JOURNAL OF HYPERTENSION
- Critical role of type 1 plasminogen activator inhibitor (PAI-1) in early host defense against nontypeable Haemophilus influenzae (NTHi) infection
- (2011) Jae Hyang Lim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Metabolic syndrome: definitions and controversies
- (2011) Eva Kassi et al. BMC Medicine
- Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
- (2011) Zaid Al-Hamodi et al. Cardiovascular Diabetology
- Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome
- (2011) Roberto Fogari et al. HYPERTENSION RESEARCH
- Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and PAI-1 plasma levels in young patients with ischemic stroke
- (2011) Adriano de Paula Sabino et al. MOLECULAR BIOLOGY REPORTS
- PAI-1 is an essential component of the pulmonary host response during Pseudomonas aeruginosa pneumonia in mice
- (2011) A. Goolaerts et al. THORAX
- Association of vitronectin and plasminogen activator inhibitor-1 levels with the risk of metabolic syndrome and type 2 diabetes mellitus
- (2011) Marie-Christine Alessi et al. THROMBOSIS AND HAEMOSTASIS
- Obesity and pulmonary embolism: The mounting evidence of risk and the mortality paradox
- (2011) Paul D. Stein et al. THROMBOSIS RESEARCH
- Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1
- (2010) M. E. Meltzer et al. BLOOD
- The Hemostatic System in Patients With Type 2 Diabetes With and Without Cardiovascular Disease
- (2010) Chantal J. N. Verkleij et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Plasma Plasminogen Activator Inhibitor 1 (PAI-1) and p-Selectin Levels in Urgent Hypertension: Effect of Single Dose Captopril and Nifedipin on Fibrinolytic Activity
- (2010) Ozlem Tiryaki et al. CLINICAL AND EXPERIMENTAL HYPERTENSION
- The metabolic syndrome
- (2010) Robert H Eckel et al. LANCET
- SEPSIS-ASSOCIATED DISSEMINATED INTRAVASCULAR COAGULATION AND THROMBOEMBOLIC DISEASE
- (2010) Nicola Semeraro et al. Mediterranean Journal of Hematology and Infectious Diseases
- PAI-1 and D-Dimer in Type 2 Diabetic Women With Asymptomatic Macrovascular Disease Assessed by Carotid Doppler
- (2009) Anna Letícia Soares et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Plasminogen Activator Inhibitor-1 (PAI-1) Gene 4G/5G Promoter Polymorphism is Seen in Higher Frequency in the Indian Patients With Deep Vein Thrombosis
- (2009) Mohammed Suhail Akhter et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Multimarker Approach to Evaluate Correlates of Vascular Stiffness
- (2008) Wolfgang Lieb et al. CIRCULATION
- Tissue Plasminogen Activator, von Willebrand Factor, and Risk of Type 2 Diabetes in Older Men
- (2008) S. G. Wannamethee et al. DIABETES CARE
- The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients
- (2008) Canan Ersoy et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Bispecific targeting of thrombin activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 by a heterodimer diabody
- (2008) J. DEVELTER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Plasminogen activator inhibitor-1 regulates neutrophil influx during acute pyelonephritis
- (2008) Joris J.T.H. Roelofs et al. KIDNEY INTERNATIONAL
- Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins
- (2008) Egbert K. O. Kruithof THROMBOSIS AND HAEMOSTASIS
- C-reactive protein increases plasminogen activator inhibitor-1 expression in human endothelial cells
- (2007) Changyi Chen et al. THROMBOSIS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started